-

LIGHTSPEED COMMERCE SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Lightspeed Commerce, Inc. - LSPD

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 18, 2022 to file lead plaintiff applications in a securities class action lawsuit against Lightspeed Commerce, Inc. (NYSE: LSPD), if they purchased the Company’s securities between September 11, 2020 and September 28, 2021, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.

What You May Do

If you purchased securities of Lightspeed and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-lspd/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by January 18, 2022.

About the Lawsuit

Lightspeed and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On September 29, 2021, Spruce Point Capital Management reported a range of allegations regarding the Company, including but not limited to, that it overstated its customer count by 85% and its gross transaction volume by 10% in pre-IPO documents; that there was “[e]vidence of declining organic growth and business deterioration through Lightspeed’s IPO, despite management’s claims that Average Revenue Per User (‘ARPU’) is increasing”; and that the Company’s “[r]ecent acquisition spree has come at escalating costs with no clear path to profitability, while management pursues aggressive revenue reporting practices.”

On this news, Lightspeed’s shares fell $13.73 per share, or 12.2%, to close at $98.77 per share on September 29, 2021.

The case is Nath v. Lightspeed Commerce Inc., et al., 21-cv-06365.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

Industry:

Kahn Swick & Foti, LLC

NYSE:LSPD
Release Versions
English

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

More News From Kahn Swick & Foti, LLC

Navan Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Navan, Inc. - NAVN

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Navan, Inc. (“Navan” or the “Company”) (NasdaqGS: NAVN).Navan, headquartered in Palo Alto, California, provides booking and expense management software for business travelers. On or about October 31, 2025, Navan conducted its initial public offering (the “IPO” or “Offering”), selling...

Sarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Sarepta Therapeutics, Inc. (NasdaqGS: SRPT) (“Sarepta” or the “Company”). Sarepta is a biopharmaceutical company focused on developing treatments for rare diseases. Sarepta's most important product is Elevidys, a therapy for the treatment of Duchenne muscular dystrophy. A...

Capital Bancorp Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Capital Bancorp, Inc. - CBNK

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Capital Bancorp, Inc. ("Capital") (NasdaqGS: CBNK) to Peoples Bancorp Inc. ("Peoples") (NasdaqGS: PEBO). Under the terms of the proposed transaction, shareholders of Capital will receive 1.11 shares of Peoples common stock for each share of Capital that they own. Upon closing of the proposed transac...
Back to Newsroom